🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Epidemiologic and Genetic Study on Familial Prostate Cancer

Recruitingn/aAges 18 Years - anyAllCentre de Recherche sur les Pathologies Prostatiq…
NCT01221168 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aims of the study are: * to identify genetic and molecular factors (rare mutations, polymorphisms) involved in the natural history of prostate cancers and their response to treatment, * to evaluate and deduce their medical applications for screening and therapeutic management of these tumors.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patient with a histological confirmed prostate cancer * member of a hereditary prostate cancer family * healthy control men without prostate cancer Exclusion Criteria: * Absence of signed informed consent * refusal to participate in the study
💊

What it tests

  • Not listed
📍

Where

5 sites
Department of Urology, CHU Angers
Angers, France
Department of Urology, Hopital de la Cavale Blanche
Brest, France
Department of Urology, CHU Dijon
Dijon, France
Department of Urology, Hopital Pitié-Salpetriere
Paris, France
Department of Urology, Hopital Tenon
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy